E-LIB Suche - Ergebnisse für: Crowley, Jeffrey J

1

Speed and Cumulative Responses According to Body Regions in..:

Gooderham, Melinda ; Vender, Ronald ; Crowley, Jeffrey...
Dermatology and Therapy. 14 (2024) 2 - p. 441-451 , 2024

Link: https://doi.org/10.1007/..

2

Efficacy of Deucravacitinib, an Oral, Selective, Allosteric..:

Blauvelt, Andrew ; Sofen, Howard ; Lambert, Jo...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s405 , 2024

Link: https://doi.org/10.25251..

3

Efficacy of long‐term risankizumab treatment for moderate‐t..:

Strober, Bruce ; Bachelez, Hervé ; Crowley, Jeffrey...
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 5 - p. 864-872 , 2024

Link: https://doi.org/10.1111/..

4

IAPAC–Lancet HIV Commission on the future of urban HIV resp..:

Zuniga, José M ; Prachniak, Corey ; Policek, Nicoletta...
The Lancet HIV. , 2024

Link: https://doi.org/10.1016/..

5

44134 Long-Term Improvement in Difficult-To-Treat Areas and..:

Elewski, Boni ; Rich, Phoebe ; Langley, Richard G....
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB190 , 2023

Link: https://doi.org/10.1016/..

6

43250 Efficacy of Apremilast in Patients With Moderate-to-S..:

Langley, Richard G. ; Mehta, Nehal N. ; Crowley, Jeffrey...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB158 , 2023

Link: https://doi.org/10.1016/..

7

42664 Itching in patients with moderate to severe plaque ps..:

Augustin, Matthias ; Langley, Richard G. ; Warren, Richard B....
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB184 , 2023

Link: https://doi.org/10.1016/..

8

44102 Risankizumab Efficacy for Moderate-to-Severe Plaque P..:

Crowley, Jeffrey ; Hong, Chih-Ho ; Gooderham, Melinda...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB82 , 2023

Link: https://doi.org/10.1016/..

9

Safety of guselkumab in patients with psoriasis with a hist..:

Blauvelt, Andrew ; Thaçi, Diamant ; Papp, Kim A...
British Journal of Dermatology. 189 (2023) 1 - p. 132-134 , 2023

Link: https://doi.org/10.1093/..

10

Guselkumab (GUS) in Psoriasis Patients With a History of Ma..:

Blauvelt, Andrew ; Thaci, Diamant ; Papp, Kim...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 2 - p. s2 , 2022

Link: https://doi.org/10.25251..

11

Efficacy of Risankizumab versus Secukinumab in Patients wit..:

Crowley, Jeffrey J. ; Langley, Richard G. ; Gordon, Kenneth B....
Dermatology and Therapy. 12 (2022) 2 - p. 561-575 , 2022

Link: https://doi.org/10.1007/..

12

Switching to risankizumab from ustekinumab or adalimumab in..:

Strober, Bruce ; Armstrong, April ; Rubant, Simone...
Journal of Dermatological Treatment. 33 (2022) 7 - p. 2991-2996 , 2022

Link: https://doi.org/10.1080/..

13

Clinical Characteristics and HealthCare Resource Utilizatio..:

Crowley, Jeffrey ; Golembesky, Amanda K. ; Kotowsky, Nirali...
Journal of Psoriasis and Psoriatic Arthritis. 6 (2021) 3 - p. 151-158 , 2021

Link: https://doi.org/10.1177/..

14

25144 Challenges in educating and counseling patients with ..:

Crowley, Jeffrey ; Murray, Suzanne ; Gooderham, Melinda J....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB4 , 2021

Link: https://doi.org/10.1016/..

15

25597 Improvements in scalp and nail psoriasis with apremil..:

Crowley, Jeffrey ; Gooderham, Melinda ; Richter, Sven..
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB62 , 2021

Link: https://doi.org/10.1016/..